In this webcast professionals from KPMG, J.P. Morgan, and Nasdaq provide their insights and perspectives on the IPO market for the life sciences industry.
Topics discussed on this webcast include:
- Capital markets update for the life sciences industry
- Impact of COVID-19 on the life sciences ecosystem
- IPO market dynamics: potential “IPO windows” for the balance of 2020, the virtual IPO roadshow, and investor risk tolerance for new issuance
- Guidance for leaders at both late-stage life sciences companies (who hope to IPO in 2020) and early-stage life sciences companies (who are interested in an IPO down the road)
The Pulse Series of reports analyze the latest global and regional trends in venture capital and fintech investments.
IPO Boot Camps
Preparing to go public? Wondering what to expect after the IPO? Join KPMG for our IPO Boot Camps held in KPMG offices across the U.S.